Symptomatic COVID-19 Infection Fatality Rate 1.3% in US
County-specific infection fatality rates for symptomatic cases varied from 0.5 to 3.6%.
COVID19
Successful Management of Severe COVID-19 in Otherwise Healthy Pediatric Patient
Sustained improvement was noted after the administration of tocilizumab, an interleukin-6 antagonist.
FDA: Scammers Continue to Sell Unproven Products for COVID-19
The FDA provided an update on its efforts to combat the sale of fraudulent products during the coronavirus disease 2019 (COVID-19) pandemic.
New York State Reports Cases of Pediatric Inflammatory Syndrome Tied to COVID-19
Pediatric patients presenting with compatible symptoms should undergo SARS-CoV-2 testing.
Doubt Cast on Notion That New Strain of COVID-19 Is More Infectious
Former FDA head says research ‘doesn’t prove that this new strain is in fact more infectious’.
Anticoagulation May Improve Outcomes in COVID-19 Patients
Longer duration of AC treatment linked to reduced risk for mortality in hospitalized patients.
COVID-19 mRNA Vaccine Candidates Advancing Through the Pipeline
A phase 2 study of Moderna’s vaccine candidate for COVID-19, mRNA-1273, is expected to start shortly following the Food and Drug Administration’s review of the Company’s Investigational New Drug (IND) application.
MPR Weekly Dose Podcast Episode 33
This week we cover the the risk of antihypertensive med use during the pandemic; The Emergency Use Authorization for remdesivir in hospitalized patients with suspected or confirmed COVID-19; The addition of a Boxed Warning to Montelukast; A new Farxiga indication; And a novel treatment for acute migraines.
New Coronavirus Strain More Contagious, Scientists Say
New strain spreads faster and may make people susceptible to a second COVID-19 infection.
Antihypertensive Medication Use Not Linked to Risk for COVID-19
“There was no association between any single medication class and an increased likelihood of a positive test,” the study authors reported. They added, “None of the medications examined was associated with a substantial increase in the risk of severe illness among patients who tested positive.”
